Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra, - Ustekinumab - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2017-10-03 19:39:42		Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra, Add to Reading List Source URL: www.visterrainc.com Download Document from Source Website File Size: 74,04 KB Share Document on Facebook